comparemela.com

Italy Srl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Selinexor Maintenance Leads to PFS Benefit in TP53 Wild-Type Advanced/Recurrent Endometrial Cancer

Maintenance therapy with selinexor improved progression-free survival compared with placebo in patients with TP53 wild-type advanced or recurrent endometrial cancer, regardless of microsatellite instability status.

Five junior and mid-level architecture and design roles

We've selected five opportunities for junior to mid-level architects and designers on Dezeen Jobs, including positions at ACME, Ben Thompson and OMA.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.